Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00822627 · ClinicalTrials.gov registry record · NA

Influenza Vaccination in the Emergency Department

A NA study of Influenza, sponsored by University of Arizona.

Completed
Registry status
NA
Development phase
140
Enrollment target
1
Study location

NCT00822627: Completed NA study of Influenza, sponsored by University of Arizona.

NCT00822627 is a NA study of Influenza that has completed, run by University of Arizona. The registered enrollment target is 140 participants, below the 36,803-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00822627, a NA study of Influenza, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
NA
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

Randomized controlled trial of influenza vaccination versus referral for vaccination in the Emergency department. Is the Emergency Department an effective venue for vaccination for influenza? Does vaccination for influenza in the Emergency Department change the rates of influenza, influenza-like-illness or medical provider visits when compared with patient referred for vaccination in the community?

Conditions Studied

Interventions

  • DRUG Influenza Vaccination
  • BEHAVIORAL Education and referral

Study Locations (1)

Arizona

  • University of Arizona - Tucson

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2007-11
Est. Completion 2008-04
Phase NA
University of Arizona

349 total trials

What the finished NCT00822627 record still lists

NCT00822627 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 36,803-participant average among 156 other Influenza trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 2 interventions - of which Influenza Vaccination is the first listed.

NCT00822627 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT00822627 about?

NCT00822627 is a clinical study titled "Influenza Vaccination in the Emergency Department". Randomized controlled trial of influenza vaccination versus referral for vaccination in the Emergency department. Is the Emergency Department an effective venue for vaccination for influenza? Does vaccination for influenza in the Emergency Department change the rates of influenza, influenza-like-ill...

What is the current status of trial NCT00822627?

This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2007-11. Estimated completion is 2008-04.

What conditions does trial NCT00822627 study?

This clinical trial studies the following conditions: Influenza.

What interventions are being tested in trial NCT00822627?

The interventions under investigation include: Influenza Vaccination (DRUG), Education and referral (BEHAVIORAL).

Who is sponsoring clinical trial NCT00822627?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00822627 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Influenza

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00822627's enrollment target sits among peer trials

140 94th of 156 higher than 63 of 156 other Influenza trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Influenza trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01419561 · 140 participants · Phase 2

    Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

  • NCT01624805 · 140 participants · Phase 2

    Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

  • NCT02369770 · 140 participants · NA

    Sensory-Motor Rehabilitation Post Stroke

  • NCT02455193 · 140 participants · NA

    Neuronal Effects of Exercise in Schizophrenia

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00822627, the US trial registry maintained by the National Library of Medicine. NCT00822627 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.